Histone deacetylase inhibitor valproic acid (VPA) promotes the epithelial mesenchymal transition of colorectal cancer cells via up regulation of Snail
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Histone deacetylase inhibitor valproic acid (VPA) promotes the epithelial mesenchymal transition of colorectal cancer cells via up regulation of Snail
Authors
Keywords
-
Journal
Cell Adhesion & Migration
Volume 9, Issue 6, Pages 495-501
Publisher
Informa UK Limited
Online
2015-12-03
DOI
10.1080/19336918.2015.1112486
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Bisphenol A modulates colorectal cancer protein profile and promotes the metastasis via induction of epithelial to mesenchymal transitions
- (2014) Zhuo-Jia Chen et al. ARCHIVES OF TOXICOLOGY
- Histone deacetylase inhibitors and cell death
- (2014) Jing Zhang et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- VPA inhibits renal cancer cell migration by targeting HDAC2 and down-regulating HIF-1α
- (2014) Feng-qiang Yang et al. MOLECULAR BIOLOGY REPORTS
- Molecular mechanisms of epithelial–mesenchymal transition
- (2014) Samy Lamouille et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The activation of G protein-coupled receptor 30 (GPR30) inhibits proliferation of estrogen receptor-negative breast cancer cells in vitro and in vivo
- (2014) W Wei et al. Cell Death & Disease
- Migration, Proliferation, and Differentiation of Cord Blood Mesenchymal Stromal Cells Treated with Histone Deacetylase Inhibitor Valproic Acid
- (2014) Leah A. Marquez-Curtis et al. Stem Cells International
- Gene expression-based prediction of myeloma cell sensitivity to histone deacetylase inhibitors
- (2013) J Moreaux et al. BRITISH JOURNAL OF CANCER
- Epithelial–Mesenchymal Transition (EMT) Induced by TNF-α Requires AKT/GSK-3β-Mediated Stabilization of Snail in Colorectal Cancer
- (2013) Hao Wang et al. PLoS One
- PI3K and Akt as molecular targets for cancer therapy: current clinical outcomes
- (2012) Ipsita Pal et al. ACTA PHARMACOLOGICA SINICA
- Enhanced suppression of proliferation and migration in highly-metastatic lung cancer cells by combination of valproic acid and coumarin-3-carboxylic acid and its molecular mechanisms of action
- (2012) Xin Liu et al. CYTOTECHNOLOGY
- Sodium valproate inhibits MDA-MB-231 breast cancer cell migration by upregulating NM23H1 expression
- (2012) G.-F. Li et al. GENETICS AND MOLECULAR RESEARCH
- Long-term results and prognostic factors after resection of hepatic and pulmonary metastases of colorectal cancer
- (2012) Silke Schüle et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Valproic acid affected the survival and invasiveness of human glioma cells through diverse mechanisms
- (2012) Yun Chen et al. JOURNAL OF NEURO-ONCOLOGY
- Histone Deacetylase Inhibitors Induce Epithelial-to-Mesenchymal Transition in Prostate Cancer Cells
- (2012) Dejuan Kong et al. PLoS One
- The regulation of cell-cell adhesion during epithelial-mesenchymal transition, motility and tumor progression
- (2012) Grégoire F. Le Bras et al. Cell Adhesion & Migration
- Valproic acid decreases urothelial cancer cell proliferation and induces thrombospondin-1 expression
- (2012) Timothy K Byler et al. BMC Urology
- HDAC inhibitors in cancer biology: emerging mechanisms and clinical applications
- (2011) Omar Khan et al. IMMUNOLOGY AND CELL BIOLOGY
- Studies Using anin VitroModel Show Evidence of Involvement of Epithelial-Mesenchymal Transition of Human Endometrial Epithelial Cells in Human Embryo Implantation
- (2011) Hiroshi Uchida et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeting Epigenetic Regulation of miR-34a for Treatment of Pancreatic Cancer by Inhibition of Pancreatic Cancer Stem Cells
- (2011) Dara Nalls et al. PLoS One
- Cell type-specific anti-cancer properties of valproic acid: independent effects on HDAC activity and Erk1/2 phosphorylation
- (2010) Kamil Gotfryd et al. BMC CANCER
- A systems view of epithelial–mesenchymal transition signaling states
- (2010) Stuart Thomson et al. CLINICAL & EXPERIMENTAL METASTASIS
- Histone deacetylase 1 is required for transforming growth factor-β1-induced epithelial–mesenchymal transition
- (2010) Weiwei Lei et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- HDAC inhibitor vorinostat enhances the antitumor effect of gefitinib in squamous cell carcinoma of head and neck by modulating ErbB receptor expression and reverting EMT
- (2010) Francesca Bruzzese et al. JOURNAL OF CELLULAR PHYSIOLOGY
- MS-275 Sensitizes TRAIL-Resistant Breast Cancer Cells, Inhibits Angiogenesis and Metastasis, and Reverses Epithelial-Mesenchymal Transition In vivo
- (2010) R. K. Srivastava et al. MOLECULAR CANCER THERAPEUTICS
- EMT, the cytoskeleton, and cancer cell invasion
- (2009) Mahmut Yilmaz et al. CANCER AND METASTASIS REVIEWS
- Cancer Metastasis Is Accelerated through Immunosuppression during Snail-Induced EMT of Cancer Cells
- (2009) Chie Kudo-Saito et al. CANCER CELL
- Epithelial-Mesenchymal Transitions in Development and Disease
- (2009) Jean Paul Thiery et al. CELL
- Biomarkers for epithelial-mesenchymal transitions
- (2009) Michael Zeisberg et al. JOURNAL OF CLINICAL INVESTIGATION
- Efficacy of anti-epileptic drugs in patients with gliomas and seizures
- (2009) Mèlanie S. M. Breemen et al. JOURNAL OF NEUROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started